Oura Delays Nasdaq IPO Citing Market Uncertainty Despite Strong Demand

Oura, a health technology company, has postponed its planned IPO on the Nasdaq, citing uncertainty in the IPO market despite reporting strong demand. The delay signals continued volatility in the equity capital markets and may reflect broader caution among tech issuers. The move is notable as it comes amid a period of mixed market sentiment, suggesting that even well-received offerings are being deferred.